Common Stock, Shares, Outstanding of Nuo Therapeutics, Inc. from Q4 2010 to Q3 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Nuo Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding history and change rate from Q4 2010 to Q3 2025.
  • Nuo Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending 30 Sep 2025 was 47,881,121, a 2.8% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Nuo Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 47,881,121 +1,282,716 +2.8% 30 Sep 2025 10-Q 30 Oct 2025 2025 Q3
Q2 2025 46,826,478 +1,360,240 +3% 30 Jun 2025 10-Q 31 Jul 2025 2025 Q2
Q1 2025 46,816,114 +2,574,598 +5.8% 31 Mar 2025 10-Q 30 Apr 2025 2025 Q1
Q4 2024 46,816,114 +2,574,598 +5.8% 31 Dec 2024 10-Q 30 Oct 2025 2025 Q3
Q3 2024 46,598,405 +4,281,889 +10% 30 Sep 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 45,466,238 +3,667,222 +8.8% 30 Jun 2024 10-Q 12 Aug 2024 2024 Q2
Q1 2024 44,241,516 +2,442,500 +5.8% 31 Mar 2024 10-Q 15 May 2024 2024 Q1
Q4 2023 44,241,516 +2,442,500 +5.8% 31 Dec 2023 10-K 01 Apr 2025 2024 FY
Q3 2023 42,316,516 +517,500 +1.2% 30 Sep 2023 10-Q 20 Nov 2023 2023 Q3
Q2 2023 41,799,016 +717,054 +1.7% 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 41,799,016 +4,674,811 +13% 31 Mar 2023 10-Q 15 May 2023 2023 Q1
Q4 2022 41,799,016 +4,674,811 +13% 31 Dec 2022 10-K 19 Apr 2024 2023 FY
Q3 2022 41,799,016 +11,540,272 +38% 30 Sep 2022 10-Q 04 Nov 2022 2022 Q3
Q2 2022 41,081,962 +10,823,218 +36% 30 Jun 2022 10-Q/A 10 Aug 2022 2022 Q2
Q1 2022 37,124,205 +6,865,461 +23% 31 Mar 2022 10-Q 16 May 2022 2022 Q1
Q4 2021 37,124,205 +6,865,461 +23% 31 Dec 2021 10-K 17 Apr 2023 2022 FY
Q3 2021 30,258,744 +6,011,344 +25% 30 Sep 2021 10-Q 04 Nov 2022 2021 Q3
Q2 2021 30,258,744 +6,011,344 +25% 30 Jun 2021 10-K 15 Apr 2022 2021 FY
Q1 2021 30,258,744 +6,011,344 +25% 31 Mar 2021 10-K 15 Apr 2022 2021 FY
Q4 2020 30,258,744 +6,536,344 +28% 31 Dec 2020 10-Q 04 Nov 2022 2021 Q3
Q3 2020 24,247,400 +525,000 +2.2% 30 Sep 2020 10-K 15 Apr 2022 2021 FY
Q2 2020 24,247,400 +525,000 +2.2% 30 Jun 2020 10-K 15 Apr 2022 2021 FY
Q1 2020 24,247,400 +525,000 +2.2% 31 Mar 2020 10-K 15 Apr 2022 2021 FY
Q4 2019 23,722,400 0 0% 31 Dec 2019 10-K 15 Apr 2022 2021 FY
Q3 2019 23,722,400 0 0% 30 Sep 2019 10-Q 31 Jan 2020 2019 Q3
Q2 2019 23,722,400 0 0% 30 Jun 2019 10-Q 19 Aug 2019 2019 Q2
Q1 2019 23,722,400 +1,000,000 +4.4% 31 Mar 2019 10-Q 20 May 2019 2019 Q1
Q4 2018 23,722,400 +1,000,000 +4.4% 31 Dec 2018 10-Q 31 Jan 2020 2019 Q3
Q3 2018 23,722,400 +995,288 +4.4% 30 Sep 2018 10-Q 16 Nov 2018 2018 Q3
Q2 2018 23,722,400 +13,795,288 +139% 30 Jun 2018 10-Q 13 Aug 2018 2018 Q2
Q1 2018 22,722,400 +12,795,288 +129% 31 Mar 2018 10-Q 14 May 2018 2018 Q1
Q4 2017 22,722,400 +12,795,288 +129% 31 Dec 2017 10-K 16 Apr 2019 2018 FY
Q3 2017 22,727,112 +12,800,000 +129% 30 Sep 2017 10-Q 13 Nov 2017 2017 Q3
Q2 2017 9,927,112 0 0% 30 Jun 2017 10-Q 14 Aug 2017 2017 Q2
Q1 2017 9,927,112 -115,752,988 -92% 31 Mar 2017 10-Q 15 May 2017 2017 Q1
Q4 2016 9,927,112 -115,752,988 -92% 31 Dec 2016 10-K 16 Apr 2018 2017 FY
Q3 2016 9,927,112 -115,752,988 -92% 30 Sep 2016 10-Q 14 Nov 2016 2016 Q3
Q2 2016 9,927,112 -115,752,988 -92% 30 Jun 2016 10-Q 24 Oct 2016 2016 Q2
Q1 2016 125,680,100 0 0% 31 Mar 2016 10-Q 24 Oct 2016 2016 Q1
Q4 2015 125,680,100 0 0% 31 Dec 2015 10-K 29 Mar 2017 2016 FY
Q3 2015 125,680,100 +1,270,000 +1% 30 Sep 2015 10-Q 13 Nov 2015 2015 Q3
Q2 2015 125,680,100 +3,979,677 +3.3% 30 Jun 2015 10-Q 13 Aug 2015 2015 Q2
Q1 2015 125,680,100 +4,353,367 +3.6% 31 Mar 2015 10-Q 14 May 2015 2015 Q1
Q4 2014 125,680,100 +18,515,245 +17% 31 Dec 2014 10-K 24 Oct 2016 2015 FY
Q3 2014 124,410,100 +19,219,621 +18% 30 Sep 2014 10-Q 13 Nov 2014 2014 Q3
Q2 2014 121,700,423 +16,918,407 +16% 30 Jun 2014 10-Q 14 Aug 2014 2014 Q2
Q1 2014 121,326,733 +16,989,356 +16% 31 Mar 2014 10-Q 15 May 2014 2014 Q1
Q4 2013 107,164,855 +13,356,469 +14% 31 Dec 2013 10-K 31 Mar 2015 2014 FY
Q3 2013 105,190,479 +13,707,093 +15% 30 Sep 2013 10-Q 12 Nov 2013 2013 Q3
Q2 2013 104,782,016 +14,093,566 +16% 30 Jun 2013 10-Q 08 Aug 2013 2013 Q2
Q1 2013 104,337,377 +33,424,181 +47% 31 Mar 2013 10-Q 09 May 2013 2013 Q1
Q4 2012 93,808,386 +38,272,094 +69% 31 Dec 2012 10-K 31 Mar 2014 2013 FY
Q3 2012 91,483,386 +38,727,487 +73% 30 Sep 2012 10-Q 14 Nov 2012 2012 Q3
Q2 2012 90,688,450 +38,733,640 +75% 30 Jun 2012 10-Q 14 Aug 2012 2012 Q2
Q1 2012 70,913,196 31 Mar 2012 10-Q 15 May 2012 2012 Q1
Q4 2011 55,536,292 +11,432,549 +26% 31 Dec 2011 10-K 18 Mar 2013 2012 FY
Q3 2011 52,755,899 30 Sep 2011 10-Q 14 Nov 2011 2011 Q3
Q2 2011 51,954,810 30 Jun 2011 10-Q 15 Aug 2011 2011 Q2
Q4 2010 44,103,743 31 Dec 2010 10-K 29 Mar 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.